Klink letter: Epipen costs
Regarding Mylan Pharmaceutical’s Epipen:
When someone eventually dies because they or their parents couldn’t afford the product, why shouldn’t their CEO be charged with manslaughter?
Paul Klink, Boise
This story was originally published August 30, 2016 at 11:28 PM with the headline "Klink letter: Epipen costs."